WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009139076) LIPOPROTEIN LIPASE-ACTIVATING COMPOSITIONS COMPRISING BENZENE DERIVATES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/139076    International Application No.:    PCT/JP2008/059294
Publication Date: 19.11.2009 International Filing Date: 14.05.2008
IPC:
A61K 31/4164 (2006.01), A61K 31/4184 (2006.01), A61K 31/4188 (2006.01), A61K 31/428 (2006.01), A61K 31/4745 (2006.01), A61K 31/519 (2006.01), A61P 3/04 (2006.01), A61P 3/06 (2006.01), C07D 233/58 (2006.01), C07D 235/18 (2006.01), C07D 277/66 (2006.01), C07D 471/04 (2006.01), C07D 487/04 (2006.01), C07D 513/04 (2006.01)
Applicants: OTSUKA PHARMACEUTICAL FACTORY, INC. [JP/JP]; 115, Aza Kuguhara, Tateiwa, Muya-cho, Naruto-shi, Tokushima 7728601 (JP) (For All Designated States Except US).
NEAGU, Irina [RO/US]; (US) (For US Only).
OHLMEYER, Michael [US/US]; (US) (For US Only).
PARADKAR, Vidyadhar, M. [US/US]; (US) (For US Only).
SAIONZ, Kurt, W. [US/US]; (US) (For US Only).
IWATA, Koushi [JP/JP]; (JP) (For US Only).
OKAMURA, Takashi [JP/JP]; (JP) (For US Only).
SHIBUTANI, Tadao [JP/JP]; (JP) (For US Only)
Inventors: NEAGU, Irina; (US).
OHLMEYER, Michael; (US).
PARADKAR, Vidyadhar, M.; (US).
SAIONZ, Kurt, W.; (US).
IWATA, Koushi; (JP).
OKAMURA, Takashi; (JP).
SHIBUTANI, Tadao; (JP)
Agent: Saegusa & Partners; Kitahama TNK Building, 1-7-1, Doshomachi, Chuo-ku Osaka-shi, Osaka, 5410045 (JP)
Priority Data:
Title (EN) LIPOPROTEIN LIPASE-ACTIVATING COMPOSITIONS COMPRISING BENZENE DERIVATES
(FR) COMPOSITIONS ACTIVANT LA LIPOPROTÉINE LIPASE RENFERMANT DES DÉRIVÉS BENZÉNIQUES
Abstract: front page image
(EN)The present invention provides pharmaceutical compositions containing benzene compound(s) represented by General Formula (1) below and, particularly, LPL-activating compositions for use in hyperlipidemia therapeutic and preventive agents, anti-obesity agents, and the like: wherein R1, R2, R3 and R4 are as defined in the specification.
(FR)La présente invention concerne des compositions pharmaceutiques renfermant un/des composé(s) benzénique(s) représenté(s) par la formule générale (1) ci-dessous et, particulièrement, des compositions activant la LPL en vue d’une utilisation dans des agents thérapeutiques et préventifs d’hyperlipidémies, des agents anti-obésité, et analogues : dans laquelle R1, R2, R3 et R4 sont tels que définis dans le mémoire.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)